Maryland State Retirement & Pension System Nektar Therapeutics Transaction History

Maryland State Retirement & Pension System

  • $4.65 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023
BUY
$2.03 - $4.28 $157,282 - $331,610
77,479 New
77,479 $0
Q2 2022

Aug 01, 2022
SELL
$3.17 - $6.17 $41,844 - $81,444
-13,200 Reduced 15.03%
74,651 $284,000
Q1 2022

Apr 11, 2022
BUY
$4.16 - $13.72 $4,472 - $14,749
1,075 Added 1.24%
87,851 $473,000
Q4 2021

Feb 09, 2022
BUY
$10.83 - $18.41 $796,828 - $1.35 Million
73,576 Added 557.39%
86,776 $1.17 Million
Q1 2021

May 10, 2021
BUY
$16.56 - $25.46 $218,591 - $336,072
13,200 New
13,200 $264,000

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $174M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Maryland State Retirement & Pension System Portfolio

Follow Maryland State Retirement & Pension System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email